HiProSUN
Roth
About HiProSUN
Our process converts waste into high-protein food and feed as well as a green energy source, solving two fundamental problems facing humanity: climate protection and nutrition. The sustainable, modular solution, which is based on GMO-free resources, has been industrially tested and can be implemented by our industrial partners (technology concerns) at customers worldwide at any time. The focus is currently on the licence business and the introduction and penetration of markets, followed by the construction of our own industrial plants. 34 patents worldwide Problem >>The production of sunflower oil produces approx. 60% meal (practically waste), which contains high-quality proteins. Oil can only be produced to the extent that this waste can be re-housed. Animal feed from soy meal, rainforest is cleared for it. Product >> Makes the waste 100% usable; high protein is produced, for animal feed (protein over 46%), so that soybean meal can be displaced from the market by sunflower (protection of rainforest); an energy source is produced from the remaining fibre content; Sales channels & promotion >> We grant licences for the patented process to existing millers. These pay an amount per tonne. The licences are distributed through sales agents (target group: seed and feed traders). In addition, direct approach to mills. Construction of own plant (60,000 t annual capacity). Results >> In the calculated normal case (for annual capacity of a plant in Germany of 240,000 t), the mix of the products HiProSUN I, HiProSUN II and HiProSUN III results in a net profit of 57% and an EBITDA of 51%.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $26.3K
- Funding stage: Seed
- Last round: Seed (Apr 2024)
- Website: hiprosun.com
- Phone: +49 9171 8399837
Industries & Categories
AgTech, Alternative Protein, Animal Feed, Clean Energy, CleanTech
Social Profiles
Canonical: https://fsome.com/organization/hiprosun-136291 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.